Literature DB >> 7000497

Effects of semistarvation on skeletal homeostasis.

R Shires, L V Avioli, M A Bergfeld, M D Fallon, E Slatopolsky, S L Teitelbaum.   

Abstract

Rats were semistarved over a 7-week period, resulting in a loss of 28.2 +/- 1.6% (SEM) of their initial body weights, while ad libitum fed controls gained 15.1 +/- 1.8% (SEM). Bone loss occurred and skeletal turnover was markedly reduced in the semistarved rats, as evidenced by a paucity of osteoid and osteoclasts, failure of the bone to assume a tetracycline label, and reduced urinary hydroxyproline excretion. Despite these changes, there were no alterations of serum or bone alkaline phosphatase activity with semistarvation, and analysis of tibial mineral content revealed reductions only in magnesium and sodium. The malnourished animals, however, were hypercalciuric and hypophosphatemic. Semistarvation had no effect on circulating levels of immunoreactive parathyroid hormone or 25-hydroxyvitamin D, but did result in reduced serum levels of corticosterone, insulin, and 1,25-dihydroxyvitamin D. Therefore, it appears that the effects of semistarvation on the rat skeleton are osteoporotic rather than osteomalacic, and that the defect is the consequence of reduced bone turnover. The contribution which the abnormalities of bone-regulating hormones play in the genesis of this skeletal lesion remains to be determined.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7000497     DOI: 10.1210/endo-107-5-1530

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  12 in total

Review 1.  Osteoporosis and diabetes mellitus.

Authors:  Angela M Inzerillo; Solomon Epstein
Journal:  Rev Endocr Metab Disord       Date:  2004-08       Impact factor: 6.514

2.  Diabetic bone disease.

Authors:  R Bouillon
Journal:  Calcif Tissue Int       Date:  1991-09       Impact factor: 4.333

3.  Talc granulomatosis in the rat. Involvement of bone in the acute-phase response.

Authors:  A Marusić; K Kos; A Stavljenić; S Vukicević
Journal:  Inflammation       Date:  1990-04       Impact factor: 4.092

4.  The effect of high-dose salmon calcitonin on bone mineral metabolism in the normal rat.

Authors:  N Glajchen; S Thomas; P Jowell; S Epstein; F Ismail; M Fallon
Journal:  Calcif Tissue Int       Date:  1990-01       Impact factor: 4.333

5.  Mixed-sclerosing-bone-dystrophy: 42-year follow-up of a case reported as osteopetrosis.

Authors:  R Pacifici; W A Murphy; S L Teitelbaum; M P Whyte
Journal:  Calcif Tissue Int       Date:  1986-03       Impact factor: 4.333

6.  Energy restriction is associated with lower bone mineral density of the tibia and femur in lean but not obese female rats.

Authors:  Jaleah Hawkins; Mariana Cifuentes; Nancy L Pleshko; Hasina Ambia-Sobhan; Sue A Shapses
Journal:  J Nutr       Date:  2009-11-18       Impact factor: 4.798

7.  Short-term aluminum administration in the rat. Effects on bone formation and relationship to renal osteomalacia.

Authors:  W G Goodman; J Gilligan; R Horst
Journal:  J Clin Invest       Date:  1984-01       Impact factor: 14.808

8.  Skeletal manifestations of lysinuric protein intolerance. A follow-up study of 29 patients.

Authors:  E Svedström; K Parto; M Marttinen; P Virtama; O Simell
Journal:  Skeletal Radiol       Date:  1993       Impact factor: 2.199

9.  Lack of change of cancellous bone volume with short-term use of the new immunosuppressant rapamycin in rats.

Authors:  I Joffe; I Katz; S Sehgal; F Bex; Y Kharode; J Tamasi; S Epstein
Journal:  Calcif Tissue Int       Date:  1993-07       Impact factor: 4.333

10.  Osteoporosis in lysinuric protein intolerance.

Authors:  K Parto; R Penttinen; I Paronen; L Pelliniemi; O Simell
Journal:  J Inherit Metab Dis       Date:  1993       Impact factor: 4.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.